Related Articles
Two postoperative chemotherapies for gastric cancer: FOLFOX4 vs. TPF
Effect of celecoxib plus standard chemotherapy on serum levels of vascular endothelial growth factor and cyclooxygenase‑2 in patients with gastric cancer
Effects of cytokine‑induced killer cell treatment combined with FOLFOX4 on the recurrence and survival rates for gastric cancer following surgery
Comparison of adjuvant FOLFOX4 chemotherapy and oral UFUR/LV following adjuvant FOLFOX4 chemotherapy in patients with stage III colon cancer subsequent to radical resection
Chemotherapy regimen based on sorafenib combined with 5-FU on HIF-1α and VEGF expression and survival in advanced gastric cancer patients